Gene: KIF3B
Official Full Name: kinesin family member 3Bprovided by HGNC
Gene Summary: The protein encoded by this gene acts as a heterodimer with kinesin family member 3A to aid in chromosome movement during mitosis and meiosis. The encoded protein is a plus end-directed microtubule motor and can interact with the SMC3 subunit of the cohesin complex. In addition, the encoded protein may be involved in the intracellular movement of membranous organelles. This protein and kinesin family member 3A form the kinesin II subfamily of the kinesin superfamily. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33290 | KIF3B Knockout cell line (HeLa) | Human | KIF3B | 1:3~1:6 | Negative | Online Inquiry |
KO33291 | KIF3B Knockout cell line (HCT 116) | Human | KIF3B | 1:2~1:4 | Negative | Online Inquiry |
KO33292 | KIF3B Knockout cell line (HEK293) | Human | KIF3B | 1:3~1:6 | Negative | Online Inquiry |
KO33293 | KIF3B Knockout cell line (A549) | Human | KIF3B | 1:3~1:4 | Negative | Online Inquiry |
KIF3B Gene Knockout Cell Lines are specialized cellular systems developed to facilitate the study of the KIF3B gene, a critical member of the kinesin family of motor proteins. This gene plays a pivotal role in microtubule-based transport within cells, specifically in intracellular movement associated with organelles, vesicles, and signaling complexes. By utilizing CRISPR-Cas9 technology or similar gene-editing methodologies, these cell lines are engineered to knock out the KIF3B gene, disrupting its function and thereby allowing researchers to investigate the consequences of its absence on cellular behavior and physiological processes.
The primary function of KIF3B is to serve as a motor protein that transports various cellular cargo along the microtubules, contributing to essential cellular functions such as cell division, morphology, and signaling pathways. By using KIF3B knockout cell lines, researchers can gain insights into the roles of kinesin proteins in cellular organization and identify potential pathways involved in diseases where kinesin dysfunction is implicated, such as neurodegenerative disorders and cancer.
Scientifically, these cell lines are invaluable as they offer a controlled environment for studying the effects of KIF3B loss in vitro, providing a platform for drug screening, target validation, and mechanistic studies. Compared to traditional gene knockout methods, KIF3B knockout cell lines present a more streamlined approach, allowing for precise gene editing and reduced off-target effects, which leads to more reliable and reproducible results.
The advantages of using KIF3B Gene Knockout Cell Lines include enhanced specificity in gene targeting, greater efficiency in functional studies, and the potential to model pathological conditions. These factors make them highly desirable tools for researchers and clinicians aiming to unravel complex cellular dynamics or explore therapeutic targets.
Our company is dedicated to advancing scientific research by providing high-quality biological products, including advanced gene knockout cell lines. With a team of experts and cutting-edge technologies, we ensure that our offerings not only meet the highest standards of scientific rigor but also empower researchers to make significant strides in understanding cellular functions and developing innovative treatments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.